Literature DB >> 35506003

The Gut Microbiome and Nonalcoholic Steatohepatitis.

Jörn M Schattenberg1.   

Abstract

Entities:  

Year:  2022        PMID： 35506003      PMCID： PMC9053482     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  6 in total

1.  Improvement of non-invasive markers of NAFLD from an individualised, web-based exercise program.

Authors:  Yvonne Huber; Daniel Pfirrmann; Ines Gebhardt; Christian Labenz; Nadine Gehrke; Beate K Straub; Christian Ruckes; Heike Bantel; Eugenio Belda; Karine Clément; Diana J Leeming; Morten A Karsdal; Peter R Galle; Perikles Simon; Jörn M Schattenberg
Journal:  Aliment Pharmacol Ther       Date:  2019-07-25       Impact factor: 8.171

2.  Gut microbiome composition in lean patients with NASH is associated with liver damage independent of caloric intake: A prospective pilot study.

Authors:  S M B Duarte; J T Stefano; L Miele; F R Ponziani; M Souza-Basqueira; L S R R Okada; F G de Barros Costa; K Toda; D F C Mazo; E C Sabino; F J Carrilho; A Gasbarrini; C P Oliveira
Journal:  Nutr Metab Cardiovasc Dis       Date:  2017-10-26       Impact factor: 4.222

3.  Nonalcoholic Fatty Liver Disease in 2020.

Authors:  Jacquelyn J Maher; Jörn M Schattenberg
Journal:  Gastroenterology       Date:  2020-04-14       Impact factor: 22.682

4.  The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota.

Authors:  Jérôme Boursier; Olaf Mueller; Matthieu Barret; Mariana Machado; Lionel Fizanne; Felix Araujo-Perez; Cynthia D Guy; Patrick C Seed; John F Rawls; Lawrence A David; Gilles Hunault; Frédéric Oberti; Paul Calès; Anna Mae Diehl
Journal:  Hepatology       Date:  2016-01-13       Impact factor: 17.425

Review 5.  Beyond the Paradigm of Weight Loss in Non-Alcoholic Fatty Liver Disease: From Pathophysiology to Novel Dietary Approaches.

Authors:  Angelo Armandi; Jörn M Schattenberg
Journal:  Nutrients       Date:  2021-06-08       Impact factor: 5.717
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.